Zydus Lifesciences

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue6,2326,9767,7218,1238,040
Expenses4,5095,5385,6646,7746,807
EBITDA2,1261,9282,6892,0362,024
EBIT1,7961,4831,7831,5251,449
Profit Before Tax1,6201,3531,6601,3691,262
Net Profit1,233965.101,3411,011927.70
Financial Ratios
Operating Profit Margin34.62%27.18%30.82%26.34%26.48%
Net Profit Margin21.26%16.26%20.77%12.48%11.92%
Earning Per Share (Diluted)12.5110.3612.659.569.28
Dividends Per Share0.000.000.000.000.00